异靛甲治疗慢性粒细胞白血病5例疗效观察  

The Effect of Meisoindigo in Treatment of 5 Cases of Chronic Myelogenous Leukemia

作　　者：魏素芳[1] 

机构地区：[1]暨南大学血液病学研究室

出　　处：《暨南大学学报（自然科学与医学版）》1989年第2期45-47,共3页Journal of Jinan University(Natural Science & Medicine Edition)

摘　　要：本文报告采用新的靛玉红类似物—异靛甲治疗5例慢性粒细胞白血病的疗效观察。完全,部分缓解率80％,证实吲哚类化合物具有抗癌作用,无明显副作用,是我国目前治疗慢性粒细胞白血病一种新的有效药物。This paper reported the effect of meisoindigo in treatment of 5 cases of chronic myelogenous leukemia. The complete and partial remission rate was 80％, Which comfirmed the anticancer effect of indole comopounds and no side effect. This results showed that meisoindigo was a new and effective drug against chronic myelogenous leukemia.

关 键 词：异靛甲 白血病 

分 类 号：R733.720.5[医药卫生—肿瘤]